TY - JOUR
T1 - The effect of Agmatine administration on ischemic-reperfused isolated rat heart
AU - Greenberg, Shai
AU - George, Jacob
AU - Wollman, Yoram
AU - Shapira, Itchak
AU - Laniado, Shlomo
AU - Keren, Gad
PY - 2001
Y1 - 2001
N2 - Background: The natural polyamine Agmatine (Ag) plays a significant role in protection of nerve cell ischemic injury. A previous report indicated that Ag given intraperitoneally to rats enhanced the recovery of the heart from ischemic injury. Based on this initial observation, a larger investigation was undertaken to explore a dose-response effect and possible mechanisms underlying the protective effects. Methods: Using the modified Langendorff model, 36 isolated hearts were divided into five groups: group 1, hearts receiving 100 μM/L Ag pre-ischemia (n=7); group 2, hearts receiving 100 μM/L Ag pre- and post-ischemia, (n=7); group 3, hearts receiving 250 μM/L Ag pre-ischemia (n=7); group 4, hearts receiving 250 μM/L Ag pre- and postischemia (n=7); and group 5, hearts receiving Krebs-Hensleit solution served as control (n=8). The study design included 20 minutes of perfusion, 30 minutes of global ischemia, and 30 minutes of reperfusion. Results: After ischemia, group 2 developed higher left ventricular pressure P(max) (P<0.01), improved first-derivative of the rise (dP/dt max; P<;0.02), and fall (dP/dt min; P<0.04) in left ventricular pressure, and the area calculated under the left-ventricle developed pressure curve (pressure-time integral; P<0.015), but coronary flow was not significantly increased (P=0.06) compared to the control group. Group 1 had improved diastolic recovery: dP/dt min (P<0.05) and coronary flow (P<0.03), compared with the control group. Group 3 had improved P(max) (P<0.01), dP/dt min (P<0.01), and coronary flow (P<0.02); group 4 had no improvement in ali hemodynamic parameters. Conclusion: Low doses of Ag given pre- and post-ischemia, and high doses given only preischemia have favorable, protective effects on the hemodynamic recovery of isolated rat heart undergoing global ischemia and reperfusion.
AB - Background: The natural polyamine Agmatine (Ag) plays a significant role in protection of nerve cell ischemic injury. A previous report indicated that Ag given intraperitoneally to rats enhanced the recovery of the heart from ischemic injury. Based on this initial observation, a larger investigation was undertaken to explore a dose-response effect and possible mechanisms underlying the protective effects. Methods: Using the modified Langendorff model, 36 isolated hearts were divided into five groups: group 1, hearts receiving 100 μM/L Ag pre-ischemia (n=7); group 2, hearts receiving 100 μM/L Ag pre- and post-ischemia, (n=7); group 3, hearts receiving 250 μM/L Ag pre-ischemia (n=7); group 4, hearts receiving 250 μM/L Ag pre- and postischemia (n=7); and group 5, hearts receiving Krebs-Hensleit solution served as control (n=8). The study design included 20 minutes of perfusion, 30 minutes of global ischemia, and 30 minutes of reperfusion. Results: After ischemia, group 2 developed higher left ventricular pressure P(max) (P<0.01), improved first-derivative of the rise (dP/dt max; P<;0.02), and fall (dP/dt min; P<0.04) in left ventricular pressure, and the area calculated under the left-ventricle developed pressure curve (pressure-time integral; P<0.015), but coronary flow was not significantly increased (P=0.06) compared to the control group. Group 1 had improved diastolic recovery: dP/dt min (P<0.05) and coronary flow (P<0.03), compared with the control group. Group 3 had improved P(max) (P<0.01), dP/dt min (P<0.01), and coronary flow (P<0.02); group 4 had no improvement in ali hemodynamic parameters. Conclusion: Low doses of Ag given pre- and post-ischemia, and high doses given only preischemia have favorable, protective effects on the hemodynamic recovery of isolated rat heart undergoing global ischemia and reperfusion.
KW - Agmatine
KW - Ischemia
KW - Isolated heart
KW - Polyamines
UR - http://www.scopus.com/inward/record.url?scp=0034768080&partnerID=8YFLogxK
U2 - 10.1177/107424840100600105
DO - 10.1177/107424840100600105
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0034768080
SN - 1074-2484
VL - 6
SP - 37
EP - 45
JO - Journal of Cardiovascular Pharmacology and Therapeutics
JF - Journal of Cardiovascular Pharmacology and Therapeutics
IS - 1
ER -